New York Marijuana Sales Hit Record $512.6 Million in Q3, Reach $1.41 Billion in 2026 and $4.1 Billion Program-to-Date

New York’s legal marijuana market generated a record $512.6 million in retail sales during the third quarter of 2026, pushing year-to-date sales above $1.4 billion, according to data presented Thursday by the state Office of Cannabis Management.

The figures were presented during an October 1 meeting of the New York Cannabis Control Board. Regulators reported $1.41 billion in marijuana sales through the first nine months of the year and more than $4.1 billion in sales since the state’s adult-use market launched.

Third-quarter sales surpassed the previous quarterly record of $503.7 million set during the final quarter of 2025.

Sales have increased during each quarter of 2026. The state reported $421 million during the first quarter, followed by $479.9 million in the second quarter and $512.6 million during the third.

Monthly sales have remained relatively consistent in recent months. New York recorded $162.2 million in June, $173.7 million in July, $171.1 million in August and $167.8 million in September.

Adult-use marijuana accounted for the vast majority of those purchases. Recreational sales totaled $163 million in September, compared with approximately $4.8 million in medical marijuana sales.

Average marijuana prices have continued to decline as the market expands, although regulators said the pace of the drop has slowed in recent months. New York’s average price per unit fell from $30.07 in January to $27.64 in September, an 8.1% decrease. Prices have been relatively stable since June, however, and remain above national benchmarks tracked by the state.

Average daily marijuana sales increased from $5.41 million in June to $5.59 million in September, a 3.3% increase. July posted the highest average among the four months at $5.60 million per day.

The growth has coincided with a continued expansion in the number of operating adult-use dispensaries. The number of adult-use dispensaries recording sales increased from 685 in June to 735 in September, while annualized sales per store remained relatively stable at about $2.7 million.

Annualized adult-use sales per store declined 3.4% between June and September, despite 50 additional dispensaries recording sales. Medical dispensaries remained essentially unchanged at 27, with annualized sales per store declining from about $2.2 million to $2.1 million.

The continued sales growth comes as New York rapidly expands the number of licensed marijuana retailers.

Separate data presented Thursday showed that the state has now licensed 1,039 adult-use retailers, including microbusinesses authorized to conduct retail sales.

New York City accounts for 428 of those licenses, followed by the Mid-Hudson region with 137, the Capital District with 111 and Western New York with 101.

Regulators said New York now has approximately 5.4 licensed marijuana retailers per 100,000 residents. That puts the state above several more established recreational markets, including California at 4.6, Nevada at 3.3 and Illinois at 2.3, while remaining below Oregon, Colorado, Michigan, Washington and Massachusetts.

The Office of Cannabis Management noted that the number of dispensaries recording sales may not match the total number of licensed retailers because the sales figures are based on businesses with recorded transactions in the state’s tracking system.

New York legalized recreational marijuana in 2021, with the state’s first licensed adult-use dispensary opening in December 2022.